<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-12-20" modified="2020-04-22" version="187">
<accession>Q9UHD2</accession>
<accession>A8K4S4</accession>
<accession>Q8IYV3</accession>
<accession>Q9NUJ5</accession>
<name>TBK1_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="73">Serine/threonine-protein kinase TBK1</fullName>
<ecNumber evidence="25 35 43 45 47 48 57">2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="72">NF-kappa-B-activating kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>T2K</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="71">TANK-binding kinase 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="71 78">TBK1</name>
<name type="synonym" evidence="72">NAK</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="6694" last="6704">
<title>NF-kB activation by a signaling complex containing TRAF2, TANK, and TBK1, a novel IKK-related kinase.</title>
<authorList>
<person name="Pomerantz J.L."/>
<person name="Baltimore D."/>
</authorList>
<dbReference type="PubMed" id="10581243"/>
<dbReference type="DOI" id="10.1093/emboj/18.23.6694"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TANK AND TRAF2</scope>
<scope>MUTAGENESIS OF LYS-38</scope>
<source>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Nature" volume="404" first="778" last="782">
<title>NAK is an IkappaB kinase-activating kinase.</title>
<authorList>
<person name="Tojima Y."/>
<person name="Fujimoto A."/>
<person name="Delhase M."/>
<person name="Chen Y."/>
<person name="Hatakeyama S."/>
<person name="Nakayama K."/>
<person name="Kaneko Y."/>
<person name="Nimura Y."/>
<person name="Motoyama N."/>
<person name="Ikeda K."/>
<person name="Karin M."/>
<person name="Nakanishi M."/>
</authorList>
<dbReference type="PubMed" id="10783893"/>
<dbReference type="DOI" id="10.1038/35008109"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF NFKBIA AND IKBKB</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANTS ASP-388 AND GLN-570</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="13840" last="13847">
<title>IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2.</title>
<authorList>
<person name="Kishore N."/>
<person name="Huynh Q.K."/>
<person name="Mathialagan S."/>
<person name="Hall T."/>
<person name="Rouw S."/>
<person name="Creely D."/>
<person name="Lange G."/>
<person name="Caroll J."/>
<person name="Reitz B."/>
<person name="Donnelly A."/>
<person name="Boddupalli H."/>
<person name="Combs R.G."/>
<person name="Kretzmer K."/>
<person name="Tripp C.S."/>
</authorList>
<dbReference type="PubMed" id="11839743"/>
<dbReference type="DOI" id="10.1074/jbc.m110474200"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF SER-172</scope>
<scope>PHOSPHORYLATION AT SER-172</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="J. Immunol." volume="171" first="4304" last="4310">
<title>Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.</title>
<authorList>
<person name="Sato S."/>
<person name="Sugiyama M."/>
<person name="Yamamoto M."/>
<person name="Watanabe Y."/>
<person name="Kawai T."/>
<person name="Takeda K."/>
<person name="Akira S."/>
</authorList>
<dbReference type="PubMed" id="14530355"/>
<dbReference type="DOI" id="10.4049/jimmunol.171.8.4304"/>
</citation>
<scope>INTERACTION WITH TIRAP AND TICAM1</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Nat. Immunol." volume="4" first="491" last="496">
<title>IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.</title>
<authorList>
<person name="Fitzgerald K.A."/>
<person name="McWhirter S.M."/>
<person name="Faia K.L."/>
<person name="Rowe D.C."/>
<person name="Latz E."/>
<person name="Golenbock D.T."/>
<person name="Coyle A.J."/>
<person name="Liao S.-M."/>
<person name="Maniatis T."/>
</authorList>
<dbReference type="PubMed" id="12692549"/>
<dbReference type="DOI" id="10.1038/ni921"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="Science" volume="300" first="1148" last="1151">
<title>Triggering the interferon antiviral response through an IKK-related pathway.</title>
<authorList>
<person name="Sharma S."/>
<person name="tenOever B.R."/>
<person name="Grandvaux N."/>
<person name="Zhou G.-P."/>
<person name="Lin R."/>
<person name="Hiscott J."/>
</authorList>
<dbReference type="PubMed" id="12702806"/>
<dbReference type="DOI" id="10.1126/science.1081315"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="7780" last="7793">
<title>Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling.</title>
<authorList>
<person name="Fujita F."/>
<person name="Taniguchi Y."/>
<person name="Kato T."/>
<person name="Narita Y."/>
<person name="Furuya A."/>
<person name="Ogawa T."/>
<person name="Sakurai H."/>
<person name="Joh T."/>
<person name="Itoh M."/>
<person name="Delhase M."/>
<person name="Karin M."/>
<person name="Nakanishi M."/>
</authorList>
<dbReference type="PubMed" id="14560022"/>
<dbReference type="DOI" id="10.1128/mcb.23.21.7780-7793.2003"/>
</citation>
<scope>INTERACTION WITH AZI2</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="9698" last="9702">
<title>Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation.</title>
<authorList>
<person name="Mori M."/>
<person name="Yoneyama M."/>
<person name="Ito T."/>
<person name="Takahashi K."/>
<person name="Inagaki F."/>
<person name="Fujita T."/>
</authorList>
<dbReference type="PubMed" id="14703513"/>
<dbReference type="DOI" id="10.1074/jbc.m310616200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF IRF3</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="15652" last="15661">
<title>Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways.</title>
<authorList>
<person name="Han K.J."/>
<person name="Su X."/>
<person name="Xu L.-G."/>
<person name="Bin L.H."/>
<person name="Zhang J."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="14739303"/>
<dbReference type="DOI" id="10.1074/jbc.m311629200"/>
</citation>
<scope>INTERACTION WITH TICAM1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="53266" last="53271">
<title>NAK is recruited to the TNFR1 complex in a TNFalpha-dependent manner and mediates the production of RANTES: identification of endogenous TNFR-interacting proteins by a proteomic approach.</title>
<authorList>
<person name="Kuai J."/>
<person name="Wooters J."/>
<person name="Hall J.P."/>
<person name="Rao V.R."/>
<person name="Nickbarg E."/>
<person name="Li B."/>
<person name="Chatterjee-Kishore M."/>
<person name="Qiu Y."/>
<person name="Lin L.-L."/>
</authorList>
<dbReference type="PubMed" id="15485837"/>
<dbReference type="DOI" id="10.1074/jbc.m411037200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="55633" last="55643">
<title>Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription.</title>
<authorList>
<person name="Buss H."/>
<person name="Dorrie A."/>
<person name="Schmitz M.L."/>
<person name="Hoffmann E."/>
<person name="Resch K."/>
<person name="Kracht M."/>
</authorList>
<dbReference type="PubMed" id="15489227"/>
<dbReference type="DOI" id="10.1074/jbc.m409825200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF RELA</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="J. Virol." volume="78" first="10636" last="10649">
<title>Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.</title>
<authorList>
<person name="tenOever B.R."/>
<person name="Sharma S."/>
<person name="Zou W."/>
<person name="Sun Q."/>
<person name="Grandvaux N."/>
<person name="Julkunen I."/>
<person name="Hemmi H."/>
<person name="Yamamoto M."/>
<person name="Akira S."/>
<person name="Yeh W.C."/>
<person name="Lin R."/>
<person name="Hiscott J."/>
</authorList>
<dbReference type="PubMed" id="15367631"/>
<dbReference type="DOI" id="10.1128/jvi.78.19.10636-10649.2004"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF IRF7</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="EMBO J." volume="24" first="4018" last="4028">
<title>SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways.</title>
<authorList>
<person name="Huang J."/>
<person name="Liu T."/>
<person name="Xu L.-G."/>
<person name="Chen D."/>
<person name="Zhai Z."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="16281057"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600863"/>
</citation>
<scope>INTERACTION WITH SIKE1; IRF3; TICAM1 AND DDX58</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="Hepatology" volume="41" first="1004" last="1012">
<title>Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses.</title>
<authorList>
<person name="Otsuka M."/>
<person name="Kato N."/>
<person name="Moriyama M."/>
<person name="Taniguchi H."/>
<person name="Wang Y."/>
<person name="Dharel N."/>
<person name="Kawabe T."/>
<person name="Omata M."/>
</authorList>
<dbReference type="PubMed" id="15841462"/>
<dbReference type="DOI" id="10.1002/hep.20666"/>
</citation>
<scope>INTERACTION WITH HCV NS3 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="13640" last="13645">
<title>Viral targeting of the interferon-beta-inducing Traf family member-associated NF-kappa-B activator (TANK)-binding kinase-1.</title>
<authorList>
<person name="Unterstab G."/>
<person name="Ludwig S."/>
<person name="Anton A."/>
<person name="Planz O."/>
<person name="Dauber B."/>
<person name="Krappmann D."/>
<person name="Heins G."/>
<person name="Ehrhardt C."/>
<person name="Wolff T."/>
</authorList>
<dbReference type="PubMed" id="16155125"/>
<dbReference type="DOI" id="10.1073/pnas.0502883102"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BORNA DISEASE VIRUS P PROTEIN</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Cell" volume="127" first="157" last="170">
<title>RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival.</title>
<authorList>
<person name="Chien Y."/>
<person name="Kim S."/>
<person name="Bumeister R."/>
<person name="Loo Y.M."/>
<person name="Kwon S.W."/>
<person name="Johnson C.L."/>
<person name="Balakireva M.G."/>
<person name="Romeo Y."/>
<person name="Kopelovich L."/>
<person name="Gale M. Jr."/>
<person name="Yeaman C."/>
<person name="Camonis J.H."/>
<person name="Zhao Y."/>
<person name="White M.A."/>
</authorList>
<dbReference type="PubMed" id="17018283"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.08.034"/>
</citation>
<scope>INTERACTION WITH EXOC2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="EMBO J." volume="26" first="3451" last="3462">
<title>Involvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genes.</title>
<authorList>
<person name="Ikeda F."/>
<person name="Hecker C.M."/>
<person name="Rozenknop A."/>
<person name="Nordmeier R.D."/>
<person name="Rogov V."/>
<person name="Hofmann K."/>
<person name="Akira S."/>
<person name="Dotsch V."/>
<person name="Dikic I."/>
</authorList>
<dbReference type="PubMed" id="17599067"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601773"/>
</citation>
<scope>DOMAIN</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="EMBO J." volume="27" first="2135" last="2146">
<title>The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response.</title>
<authorList>
<person name="Soulat D."/>
<person name="Burckstummer T."/>
<person name="Westermayer S."/>
<person name="Goncalves A."/>
<person name="Bauch A."/>
<person name="Stefanovic A."/>
<person name="Hantschel O."/>
<person name="Bennett K.L."/>
<person name="Decker T."/>
<person name="Superti-Furga G."/>
</authorList>
<dbReference type="PubMed" id="18583960"/>
<dbReference type="DOI" id="10.1038/emboj.2008.126"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF DDX3X</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="EMBO Rep." volume="9" first="930" last="936">
<title>The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response.</title>
<authorList>
<person name="Friedman C.S."/>
<person name="O'Donnell M.A."/>
<person name="Legarda-Addison D."/>
<person name="Ng A."/>
<person name="Cardenas W.B."/>
<person name="Yount J.S."/>
<person name="Moran T.M."/>
<person name="Basler C.F."/>
<person name="Komuro A."/>
<person name="Horvath C.M."/>
<person name="Xavier R."/>
<person name="Ting A.T."/>
</authorList>
<dbReference type="PubMed" id="18636086"/>
<dbReference type="DOI" id="10.1038/embor.2008.136"/>
</citation>
<scope>INTERACTION WITH CYLD</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="19122" last="19131">
<title>The tyrosine kinase c-Src enhances RIG-I (retinoic acid-inducible gene I)-elicited antiviral signaling.</title>
<authorList>
<person name="Johnsen I.B."/>
<person name="Nguyen T.T."/>
<person name="Bergstroem B."/>
<person name="Fitzgerald K.A."/>
<person name="Anthonsen M.W."/>
</authorList>
<dbReference type="PubMed" id="19419966"/>
<dbReference type="DOI" id="10.1074/jbc.m808233200"/>
</citation>
<scope>INTERACTION WITH SRC</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="J. Virol." volume="83" first="3069" last="3077">
<title>Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1.</title>
<authorList>
<person name="Prins K.C."/>
<person name="Cardenas W.B."/>
<person name="Basler C.F."/>
</authorList>
<dbReference type="PubMed" id="19153231"/>
<dbReference type="DOI" id="10.1128/jvi.01875-08"/>
</citation>
<scope>INTERACTION WITH EBOLAVIRUS PROTEIN VP35</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Nat. Immunol." volume="10" first="744" last="752">
<title>The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon.</title>
<authorList>
<person name="Wang C."/>
<person name="Chen T."/>
<person name="Zhang J."/>
<person name="Yang M."/>
<person name="Li N."/>
<person name="Xu X."/>
<person name="Cao X."/>
</authorList>
<dbReference type="PubMed" id="19483718"/>
<dbReference type="DOI" id="10.1038/ni.1742"/>
</citation>
<scope>UBIQUITINATION BY NRDP1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="7945" last="7950">
<title>ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response.</title>
<authorList>
<person name="Li Y."/>
<person name="Li C."/>
<person name="Xue P."/>
<person name="Zhong B."/>
<person name="Mao A.P."/>
<person name="Ran Y."/>
<person name="Chen H."/>
<person name="Wang Y.Y."/>
<person name="Yang F."/>
<person name="Shu H.B."/>
</authorList>
<dbReference type="PubMed" id="19416887"/>
<dbReference type="DOI" id="10.1073/pnas.0900818106"/>
</citation>
<scope>INTERACTION WITH STING1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Immunity" volume="33" first="878" last="889">
<title>Glycogen synthase kinase 3beta regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1.</title>
<authorList>
<person name="Lei C.Q."/>
<person name="Zhong B."/>
<person name="Zhang Y."/>
<person name="Zhang J."/>
<person name="Wang S."/>
<person name="Shu H.B."/>
</authorList>
<dbReference type="PubMed" id="21145761"/>
<dbReference type="DOI" id="10.1016/j.immuni.2010.11.021"/>
</citation>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH GSK3B</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="J. Gen. Virol." volume="91" first="2080" last="2090">
<title>Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.</title>
<authorList>
<person name="Yu S."/>
<person name="Chen J."/>
<person name="Wu M."/>
<person name="Chen H."/>
<person name="Kato N."/>
<person name="Yuan Z."/>
</authorList>
<dbReference type="PubMed" id="20375222"/>
<dbReference type="DOI" id="10.1099/vir.0.020552-0"/>
</citation>
<scope>INTERACTION WITH DDX3X</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="PLoS Pathog." volume="6" first="E1000778" last="E1000778">
<title>Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection.</title>
<authorList>
<person name="Mankouri J."/>
<person name="Fragkoudis R."/>
<person name="Richards K.H."/>
<person name="Wetherill L.F."/>
<person name="Harris M."/>
<person name="Kohl A."/>
<person name="Elliott R.M."/>
<person name="Macdonald A."/>
</authorList>
<dbReference type="PubMed" id="20174559"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1000778"/>
</citation>
<scope>INTERACTION WITH OPTN AND TRAF3</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="Hum. Mol. Genet." volume="20" first="2482" last="2494">
<title>Copy number variations on chromosome 12q14 in patients with normal tension glaucoma.</title>
<authorList>
<person name="Fingert J.H."/>
<person name="Robin A.L."/>
<person name="Stone J.L."/>
<person name="Roos B.R."/>
<person name="Davis L.K."/>
<person name="Scheetz T.E."/>
<person name="Bennett S.R."/>
<person name="Wassink T.H."/>
<person name="Kwon Y.H."/>
<person name="Alward W.L."/>
<person name="Mullins R.F."/>
<person name="Sheffield V.C."/>
<person name="Stone E.M."/>
</authorList>
<dbReference type="PubMed" id="21447600"/>
<dbReference type="DOI" id="10.1093/hmg/ddr123"/>
</citation>
<scope>INVOLVEMENT IN GLC1P</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANTS PHE-151; ILE-306 AND ALA-464</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2011" name="Immunity" volume="35" first="426" last="440">
<title>Mapping a dynamic innate immunity protein interaction network regulating type I interferon production.</title>
<authorList>
<person name="Li S."/>
<person name="Wang L."/>
<person name="Berman M."/>
<person name="Kong Y.Y."/>
<person name="Dorf M.E."/>
</authorList>
<dbReference type="PubMed" id="21903422"/>
<dbReference type="DOI" id="10.1016/j.immuni.2011.06.014"/>
</citation>
<scope>UBIQUITINATION BY MIB1</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="J. Immunol." volume="187" first="2559" last="2568">
<title>IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging MAVS and TBK1.</title>
<authorList>
<person name="Liu X.Y."/>
<person name="Chen W."/>
<person name="Wei B."/>
<person name="Shan Y.F."/>
<person name="Wang C."/>
</authorList>
<dbReference type="PubMed" id="21813773"/>
<dbReference type="DOI" id="10.4049/jimmunol.1100963"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH IFIT3 AND MAVS</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="J. Immunol." volume="186" first="3023" last="3030">
<title>TANK-binding kinase 1 attenuates PTAP-dependent retroviral budding through targeting endosomal sorting complex required for transport-I.</title>
<authorList>
<person name="Da Q."/>
<person name="Yang X."/>
<person name="Xu Y."/>
<person name="Gao G."/>
<person name="Cheng G."/>
<person name="Tang H."/>
</authorList>
<dbReference type="PubMed" id="21270402"/>
<dbReference type="DOI" id="10.4049/jimmunol.1000262"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF VPS37C</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E23971" last="E23971">
<title>Functional dissection of the TBK1 molecular network.</title>
<authorList>
<person name="Goncalves A."/>
<person name="Burckstummer T."/>
<person name="Dixit E."/>
<person name="Scheicher R."/>
<person name="Gorna M.W."/>
<person name="Karayel E."/>
<person name="Sugar C."/>
<person name="Stukalov A."/>
<person name="Berg T."/>
<person name="Kralovics R."/>
<person name="Planyavsky M."/>
<person name="Bennett K.L."/>
<person name="Colinge J."/>
<person name="Superti-Furga G."/>
</authorList>
<dbReference type="PubMed" id="21931631"/>
<dbReference type="DOI" id="10.1371/journal.pone.0023971"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH AZI2; TANK AND TBKBP1</scope>
<scope>MUTAGENESIS OF ASP-135; MET-690; LEU-693; LYS-694; LEU-704; ASN-708 AND LEU-711</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="6474" last="6479">
<title>IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation.</title>
<authorList>
<person name="Xie X."/>
<person name="Zhang D."/>
<person name="Zhao B."/>
<person name="Lu M.K."/>
<person name="You M."/>
<person name="Condorelli G."/>
<person name="Wang C.Y."/>
<person name="Guan K.L."/>
</authorList>
<dbReference type="PubMed" id="21464307"/>
<dbReference type="DOI" id="10.1073/pnas.1016132108"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF AKT1</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2011" name="Science" volume="333" first="228" last="233">
<title>Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth.</title>
<authorList>
<person name="Wild P."/>
<person name="Farhan H."/>
<person name="McEwan D.G."/>
<person name="Wagner S."/>
<person name="Rogov V.V."/>
<person name="Brady N.R."/>
<person name="Richter B."/>
<person name="Korac J."/>
<person name="Waidmann O."/>
<person name="Choudhary C."/>
<person name="Dotsch V."/>
<person name="Bumann D."/>
<person name="Dikic I."/>
</authorList>
<dbReference type="PubMed" id="21617041"/>
<dbReference type="DOI" id="10.1126/science.1205405"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF OPTN</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="Oncogene" volume="30" first="631" last="641">
<title>Emerging roles for the non-canonical IKKs in cancer.</title>
<authorList>
<person name="Shen R.R."/>
<person name="Hahn W.C."/>
</authorList>
<dbReference type="PubMed" id="21042276"/>
<dbReference type="DOI" id="10.1038/onc.2010.493"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="Biochem. J." volume="434" first="93" last="104">
<title>Novel cross-talk within the IKK family controls innate immunity.</title>
<authorList>
<person name="Clark K."/>
<person name="Peggie M."/>
<person name="Plater L."/>
<person name="Sorcek R.J."/>
<person name="Young E.R."/>
<person name="Madwed J.B."/>
<person name="Hough J."/>
<person name="McIver E.G."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="21138416"/>
<dbReference type="DOI" id="10.1042/bj20101701"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION BY IKBKB/IKKB</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="Cell. Signal." volume="24" first="2197" last="2204">
<title>PPM1B negatively regulates antiviral response via dephosphorylating TBK1.</title>
<authorList>
<person name="Zhao Y."/>
<person name="Liang L."/>
<person name="Fan Y."/>
<person name="Sun S."/>
<person name="An L."/>
<person name="Shi Z."/>
<person name="Cheng J."/>
<person name="Jia W."/>
<person name="Sun W."/>
<person name="Mori-Akiyama Y."/>
<person name="Zhang H."/>
<person name="Fu S."/>
<person name="Yang J."/>
</authorList>
<dbReference type="PubMed" id="22750291"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2012.06.017"/>
</citation>
<scope>DEPHOSPHORYLATION AT SER-172</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2012" name="Exp. Eye Res." volume="96" first="178" last="180">
<title>Confirmation of TBK1 duplication in normal tension glaucoma.</title>
<authorList>
<person name="Kawase K."/>
<person name="Allingham R.R."/>
<person name="Meguro A."/>
<person name="Mizuki N."/>
<person name="Roos B."/>
<person name="Solivan-Timpe F.M."/>
<person name="Robin A.L."/>
<person name="Ritch R."/>
<person name="Fingert J.H."/>
</authorList>
<dbReference type="PubMed" id="22306015"/>
<dbReference type="DOI" id="10.1016/j.exer.2011.12.021"/>
</citation>
<scope>INVOLVEMENT IN GLC1P</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2012" name="J. Exp. Med." volume="209" first="1567" last="1582">
<title>Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood.</title>
<authorList>
<person name="Herman M."/>
<person name="Ciancanelli M."/>
<person name="Ou Y.H."/>
<person name="Lorenzo L."/>
<person name="Klaudel-Dreszler M."/>
<person name="Pauwels E."/>
<person name="Sancho-Shimizu V."/>
<person name="Perez de Diego R."/>
<person name="Abhyankar A."/>
<person name="Israelsson E."/>
<person name="Guo Y."/>
<person name="Cardon A."/>
<person name="Rozenberg F."/>
<person name="Lebon P."/>
<person name="Tardieu M."/>
<person name="Heropolitanska-Pliszka E."/>
<person name="Chaussabel D."/>
<person name="White M.A."/>
<person name="Abel L."/>
<person name="Zhang S.Y."/>
<person name="Casanova J.L."/>
</authorList>
<dbReference type="PubMed" id="22851595"/>
<dbReference type="DOI" id="10.1084/jem.20111316"/>
</citation>
<scope>INVOLVEMENT IN IIAE8</scope>
<scope>VARIANTS IIAE8 ALA-50 AND ALA-159</scope>
<scope>CHARACTERIZATION OF VARIANTS IIAE8 ALA-50 AND ALA-159</scope>
<scope>MUTAGENESIS OF LYS-38</scope>
<scope>PHOSPHORYLATION AT SER-172</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2012" name="J. Exp. Med." volume="209" first="1703" last="1711">
<title>TRAF-interacting protein (TRIP) negatively regulates IFN-beta production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1.</title>
<authorList>
<person name="Zhang M."/>
<person name="Wang L."/>
<person name="Zhao X."/>
<person name="Zhao K."/>
<person name="Meng H."/>
<person name="Zhao W."/>
<person name="Gao C."/>
</authorList>
<dbReference type="PubMed" id="22945920"/>
<dbReference type="DOI" id="10.1084/jem.20120024"/>
</citation>
<scope>UBIQUITINATION BY TRAIP</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2012" name="Nat. Immunol." volume="13" first="387" last="395">
<title>NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4.</title>
<authorList>
<person name="Cui J."/>
<person name="Li Y."/>
<person name="Zhu L."/>
<person name="Liu D."/>
<person name="Songyang Z."/>
<person name="Wang H.Y."/>
<person name="Wang R.F."/>
</authorList>
<dbReference type="PubMed" id="22388039"/>
<dbReference type="DOI" id="10.1038/ni.2239"/>
</citation>
<scope>UBIQUITINATION AT LYS-670 BY DTX4</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-716</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="48">
<citation type="journal article" date="2015" name="Acta Neuropathol." volume="130" first="77" last="92">
<title>Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease.</title>
<authorList>
<person name="Pottier C."/>
<person name="Bieniek K.F."/>
<person name="Finch N."/>
<person name="van de Vorst M."/>
<person name="Baker M."/>
<person name="Perkersen R."/>
<person name="Brown P."/>
<person name="Ravenscroft T."/>
<person name="van Blitterswijk M."/>
<person name="Nicholson A.M."/>
<person name="DeTure M."/>
<person name="Knopman D.S."/>
<person name="Josephs K.A."/>
<person name="Parisi J.E."/>
<person name="Petersen R.C."/>
<person name="Boylan K.B."/>
<person name="Boeve B.F."/>
<person name="Graff-Radford N.R."/>
<person name="Veltman J.A."/>
<person name="Gilissen C."/>
<person name="Murray M.E."/>
<person name="Dickson D.W."/>
<person name="Rademakers R."/>
</authorList>
<dbReference type="PubMed" id="25943890"/>
<dbReference type="DOI" id="10.1007/s00401-015-1436-x"/>
</citation>
<scope>INVOLVEMENT IN FTDALS4</scope>
<scope>VARIANTS FTDALS4 ILE-306; GLU-401 AND LYS-696</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2015" name="EMBO Rep." volume="16" first="447" last="455">
<title>WDFY1 mediates TLR3/4 signaling by recruiting TRIF.</title>
<authorList>
<person name="Hu Y.H."/>
<person name="Zhang Y."/>
<person name="Jiang L.Q."/>
<person name="Wang S."/>
<person name="Lei C.Q."/>
<person name="Sun M.S."/>
<person name="Shu H.B."/>
<person name="Liu Y."/>
</authorList>
<dbReference type="PubMed" id="25736436"/>
<dbReference type="DOI" id="10.15252/embr.201439637"/>
</citation>
<scope>INTERACTION WITH TICAM1</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2015" name="Genes Immun." volume="16" first="552" last="566">
<title>Mutations in the TLR3 signaling pathway and beyond in adult patients with herpes simplex encephalitis.</title>
<authorList>
<person name="Moerk N."/>
<person name="Kofod-Olsen E."/>
<person name="Soerensen K.B."/>
<person name="Bach E."/>
<person name="Oerntoft T.F."/>
<person name="Oestergaard L."/>
<person name="Paludan S.R."/>
<person name="Christiansen M."/>
<person name="Mogensen T.H."/>
</authorList>
<dbReference type="PubMed" id="26513235"/>
<dbReference type="DOI" id="10.1038/gene.2015.46"/>
</citation>
<scope>INVOLVEMENT IN IIAE8</scope>
<scope>VARIANT IIAE8 VAL-207</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2015" name="Nat. Neurosci." volume="18" first="631" last="636">
<title>Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia.</title>
<authorList>
<person name="Freischmidt A."/>
<person name="Wieland T."/>
<person name="Richter B."/>
<person name="Ruf W."/>
<person name="Schaeffer V."/>
<person name="Mueller K."/>
<person name="Marroquin N."/>
<person name="Nordin F."/>
<person name="Huebers A."/>
<person name="Weydt P."/>
<person name="Pinto S."/>
<person name="Press R."/>
<person name="Millecamps S."/>
<person name="Molko N."/>
<person name="Bernard E."/>
<person name="Desnuelle C."/>
<person name="Soriani M.H."/>
<person name="Dorst J."/>
<person name="Graf E."/>
<person name="Nordstroem U."/>
<person name="Feiler M.S."/>
<person name="Putz S."/>
<person name="Boeckers T.M."/>
<person name="Meyer T."/>
<person name="Winkler A.S."/>
<person name="Winkelman J."/>
<person name="de Carvalho M."/>
<person name="Thal D.R."/>
<person name="Otto M."/>
<person name="Braennstroem T."/>
<person name="Volk A.E."/>
<person name="Kursula P."/>
<person name="Danzer K.M."/>
<person name="Lichtner P."/>
<person name="Dikic I."/>
<person name="Meitinger T."/>
<person name="Ludolph A.C."/>
<person name="Strom T.M."/>
<person name="Andersen P.M."/>
<person name="Weishaupt J.H."/>
</authorList>
<dbReference type="PubMed" id="25803835"/>
<dbReference type="DOI" id="10.1038/nn.4000"/>
</citation>
<scope>INVOLVEMENT IN FTDALS4</scope>
<scope>VARIANTS FTDALS4 HIS-47; CYS-105; THR-305; GLN-308; GLN-357; ARG-559; VAL-571; VAL-598; GLU-643 DEL AND LYS-696</scope>
<scope>CHARACTERIZATION OF VARIANTS FTDALS4 HIS-47; GLN-308; GLN-357; ARG-559 AND LYS-696</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2015" name="Science" volume="347" first="AAA2630" last="AAA2630">
<title>Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation.</title>
<authorList>
<person name="Liu S."/>
<person name="Cai X."/>
<person name="Wu J."/>
<person name="Cong Q."/>
<person name="Chen X."/>
<person name="Li T."/>
<person name="Du F."/>
<person name="Ren J."/>
<person name="Wu Y.T."/>
<person name="Grishin N.V."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="25636800"/>
<dbReference type="DOI" id="10.1126/science.aaa2630"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2016" name="EMBO J." volume="35" first="1276" last="1297">
<title>Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death.</title>
<authorList>
<person name="Sellier C."/>
<person name="Campanari M.L."/>
<person name="Julie Corbier C."/>
<person name="Gaucherot A."/>
<person name="Kolb-Cheynel I."/>
<person name="Oulad-Abdelghani M."/>
<person name="Ruffenach F."/>
<person name="Page A."/>
<person name="Ciura S."/>
<person name="Kabashi E."/>
<person name="Charlet-Berguerand N."/>
</authorList>
<dbReference type="PubMed" id="27103069"/>
<dbReference type="DOI" id="10.15252/embj.201593350"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2016" name="J. Mol. Cell Biol." volume="8" first="31" last="43">
<title>Autoubiquitination of TRIM26 links TBK1 to NEMO in RLR-mediated innate antiviral immune response.</title>
<authorList>
<person name="Ran Y."/>
<person name="Zhang J."/>
<person name="Liu L.L."/>
<person name="Pan Z.Y."/>
<person name="Nie Y."/>
<person name="Zhang H.Y."/>
<person name="Wang Y.Y."/>
</authorList>
<dbReference type="PubMed" id="26611359"/>
<dbReference type="DOI" id="10.1093/jmcb/mjv068"/>
</citation>
<scope>INTERACTION WITH TRIM26</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2016" name="Nat. Immunol." volume="17" first="1342" last="1351">
<title>E3 ubiquitin ligase RNF128 promotes innate antiviral immunity through K63-linked ubiquitination of TBK1.</title>
<authorList>
<person name="Song G."/>
<person name="Liu B."/>
<person name="Li Z."/>
<person name="Wu H."/>
<person name="Wang P."/>
<person name="Zhao K."/>
<person name="Jiang G."/>
<person name="Zhang L."/>
<person name="Gao C."/>
</authorList>
<dbReference type="PubMed" id="27776110"/>
<dbReference type="DOI" id="10.1038/ni.3588"/>
</citation>
<scope>UBIQUITINATION BY RNF128</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2017" name="J. Immunol." volume="198" first="1274" last="1284">
<title>TTLL12 Inhibits the Activation of Cellular Antiviral Signaling through Interaction with VISA/MAVS.</title>
<authorList>
<person name="Ju L.G."/>
<person name="Zhu Y."/>
<person name="Lei P.J."/>
<person name="Yan D."/>
<person name="Zhu K."/>
<person name="Wang X."/>
<person name="Li Q.L."/>
<person name="Li X.J."/>
<person name="Chen J.W."/>
<person name="Li L.Y."/>
<person name="Wu M."/>
</authorList>
<dbReference type="PubMed" id="28011935"/>
<dbReference type="DOI" id="10.4049/jimmunol.1601194"/>
</citation>
<scope>INTERACTION WITH TTLL12 AND MAVS</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2017" name="Nat. Microbiol." volume="2" first="1543" last="1557">
<title>TRIM23 mediates virus-induced autophagy via activation of TBK1.</title>
<authorList>
<person name="Sparrer K.M.J."/>
<person name="Gableske S."/>
<person name="Zurenski M.A."/>
<person name="Parker Z.M."/>
<person name="Full F."/>
<person name="Baumgart G.J."/>
<person name="Kato J."/>
<person name="Pacheco-Rodriguez G."/>
<person name="Liang C."/>
<person name="Pornillos O."/>
<person name="Moss J."/>
<person name="Vaughan M."/>
<person name="Gack M.U."/>
</authorList>
<dbReference type="PubMed" id="28871090"/>
<dbReference type="DOI" id="10.1038/s41564-017-0017-2"/>
</citation>
<scope>INTERACTION WITH TRIM23</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2017" name="J. Virol." volume="91">
<title>Role of Herpes Simplex Virus 1 gamma34.5 in the Regulation of IRF3 Signaling.</title>
<authorList>
<person name="Manivanh R."/>
<person name="Mehrbach J."/>
<person name="Knipe D.M."/>
<person name="Leib D.A."/>
</authorList>
<dbReference type="PubMed" id="28904192"/>
<dbReference type="DOI" id="10.1128/jvi.01156-17"/>
</citation>
<scope>INTERACTION WITH HERPES SIMPLEX VIRUS 1 PROTEIN ICP34.5 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2018" name="Proteomics" volume="18">
<title>Quantitative Proteomics Identified TTC4 as a TBK1 Interactor and a Positive Regulator of SeV-Induced Innate Immunity.</title>
<authorList>
<person name="Shang J."/>
<person name="Xia T."/>
<person name="Han Q.Q."/>
<person name="Zhao X."/>
<person name="Hu M.M."/>
<person name="Shu H.B."/>
<person name="Guo L."/>
</authorList>
<dbReference type="PubMed" id="29251827"/>
<dbReference type="DOI" id="10.1002/pmic.201700403"/>
</citation>
<scope>INTERACTION WITH TTC4; IKBKE; AZI2 AND TANK</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2019" name="Science">
<title>Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses.</title>
<authorList>
<person name="Wang L."/>
<person name="Wen M."/>
<person name="Cao X."/>
</authorList>
<dbReference type="PubMed" id="31320558"/>
<dbReference type="DOI" id="10.1126/science.aav0758"/>
</citation>
<scope>INTERACTION WITH HNRNPA2B1</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2013" name="Cell Rep." volume="3" first="734" last="746">
<title>Crystal structure and mechanism of activation of TANK-binding kinase 1.</title>
<authorList>
<person name="Larabi A."/>
<person name="Devos J.M."/>
<person name="Ng S.L."/>
<person name="Nanao M.H."/>
<person name="Round A."/>
<person name="Maniatis T."/>
<person name="Panne D."/>
</authorList>
<dbReference type="PubMed" id="23453971"/>
<dbReference type="DOI" id="10.1016/j.celrep.2013.01.034"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 1-657 IN COMPLEX WITH INHIBITORS</scope>
<scope>FUNCTION</scope>
<scope>ACTIVE SITE</scope>
<scope>HOMODIMER</scope>
<scope>UBIQUITINATION AT LYS-30 AND LYS-401</scope>
<scope>MUTAGENESIS OF LYS-30; ASP-33; LYS-38; ASP-135; GLU-355; ARG-357; LYS-401; ARG-547; TYR-577; GLU-580; ILE-582 AND LYS-589</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2013" name="Cell Rep." volume="3" first="747" last="758">
<title>Structure and ubiquitination-dependent activation of TANK-binding kinase 1.</title>
<authorList>
<person name="Tu D."/>
<person name="Zhu Z."/>
<person name="Zhou A.Y."/>
<person name="Yun C.H."/>
<person name="Lee K.E."/>
<person name="Toms A.V."/>
<person name="Li Y."/>
<person name="Dunn G.P."/>
<person name="Chan E."/>
<person name="Thai T."/>
<person name="Yang S."/>
<person name="Ficarro S.B."/>
<person name="Marto J.A."/>
<person name="Jeon H."/>
<person name="Hahn W.C."/>
<person name="Barbie D.A."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="23453972"/>
<dbReference type="DOI" id="10.1016/j.celrep.2013.01.033"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.61 ANGSTROMS) OF 1-657 IN COMPLEX WITH INHIBITORS</scope>
<scope>FUNCTION</scope>
<scope>ACTIVE SITE</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>HOMODIMER</scope>
<scope>INTERACTION WITH AZI2</scope>
<scope>MUTAGENESIS OF LYS-38; ASP-135; SER-172; LEU-316; TYR-325; GLU-355; GLU-448; HIS-459; ILE-466 AND PHE-470</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2013" name="Structure" volume="21" first="1137" last="1148">
<title>Structural insights into the functions of TBK1 in innate antimicrobial immunity.</title>
<authorList>
<person name="Shu C."/>
<person name="Sankaran B."/>
<person name="Chaton C.T."/>
<person name="Herr A.B."/>
<person name="Mishra A."/>
<person name="Peng J."/>
<person name="Li P."/>
</authorList>
<dbReference type="PubMed" id="23746807"/>
<dbReference type="DOI" id="10.1016/j.str.2013.04.025"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 1-657 IN COMPLEX WITH INHIBITORS</scope>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-172</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2019" name="Nature" volume="567" first="394" last="398">
<title>Structural basis of STING binding with and phosphorylation by TBK1.</title>
<authorList>
<person name="Zhang C."/>
<person name="Shang G."/>
<person name="Gui X."/>
<person name="Zhang X."/>
<person name="Bai X.C."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="30842653"/>
<dbReference type="DOI" id="10.1038/s41586-019-1000-2"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF 1-729 OF MUTANT ASN-135 IN COMPLEX WITH STING1</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH STING1</scope>
<scope>ACTIVE SITE</scope>
<scope>MUTAGENESIS OF TYR-577; ASN-578 AND GLN-581</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] GLN-271; GLU-291; HIS-296; ARG-410 AND ALA-464</scope>
</reference>
<comment type="function">
<text evidence="13 16 17 18 19 20 23 25 26 27 30 35 43 45 47 48 50 53 54 55 56 57 62 63 69">Serine/threonine kinase that plays an essential role in regulating inflammatory responses to foreign agents (PubMed:12692549, PubMed:14703513, PubMed:18583960, PubMed:12702806, PubMed:15367631, PubMed:10581243, PubMed:11839743, PubMed:15485837, PubMed:21138416, PubMed:25636800, PubMed:23453971, PubMed:23453972, PubMed:23746807, PubMed:26611359). Following activation of toll-like receptors by viral or bacterial components, associates with TRAF3 and TANK and phosphorylates interferon regulatory factors (IRFs) IRF3 and IRF7 as well as DDX3X (PubMed:12692549, PubMed:14703513, PubMed:18583960, PubMed:12702806, PubMed:15367631, PubMed:25636800). This activity allows subsequent homodimerization and nuclear translocation of the IRFs leading to transcriptional activation of pro-inflammatory and antiviral genes including IFNA and IFNB (PubMed:12702806, PubMed:15367631, PubMed:25636800). In order to establish such an antiviral state, TBK1 form several different complexes whose composition depends on the type of cell and cellular stimuli (PubMed:23453971, PubMed:23453972, PubMed:23746807). Plays a key role in IRF3 activation: acts by first phosphorylating innate adapter proteins MAVS, STING1 and TICAM1 on their pLxIS motif, leading to recruitment of IRF3, thereby licensing IRF3 for phosphorylation by TBK1 (PubMed:25636800, PubMed:30842653). Phosphorylated IRF3 dissociates from the adapter proteins, dimerizes, and then enters the nucleus to induce expression of interferons (PubMed:25636800). Thus, several scaffolding molecules including FADD, TRADD, MAVS, AZI2, TANK or TBKBP1/SINTBAD can be recruited to the TBK1-containing-complexes (PubMed:21931631). Under particular conditions, functions as a NF-kappa-B effector by phosphorylating NF-kappa-B inhibitor alpha/NFKBIA, IKBKB or RELA to translocate NF-Kappa-B to the nucleus (PubMed:10783893, PubMed:15489227). Restricts bacterial proliferation by phosphorylating the autophagy receptor OPTN/Optineurin on 'Ser-177', thus enhancing LC3 binding affinity and antibacterial autophagy (PubMed:21617041). Phosphorylates SMCR8 component of the C9orf72-SMCR8 complex, promoting autophagosome maturation (PubMed:27103069). Phosphorylates and activates AKT1 (PubMed:21464307). Seems to play a role in energy balance regulation by sustaining a state of chronic, low-grade inflammation in obesity, wich leads to a negative impact on insulin sensitivity (By similarity). Attenuates retroviral budding by phosphorylating the endosomal sorting complex required for transport-I (ESCRT-I) subunit VPS37C (PubMed:21270402). Phosphorylates Borna disease virus (BDV) P protein (PubMed:16155125). Plays an essential role in the TLR3- and IFN-dependent control of herpes virus HSV-1 and HSV-2 infections in the central nervous system (PubMed:22851595).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="17 23 25 35 43 45 47 48 57">
<text>ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]</text>
<dbReference type="Rhea" id="RHEA:17989"/>
<dbReference type="Rhea" id="RHEA-COMP:9863"/>
<dbReference type="Rhea" id="RHEA-COMP:11604"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:29999"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:83421"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="2.7.11.1"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="17 23 25 35 43 45 47 48 57">
<text>ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]</text>
<dbReference type="Rhea" id="RHEA:46608"/>
<dbReference type="Rhea" id="RHEA-COMP:11060"/>
<dbReference type="Rhea" id="RHEA-COMP:11605"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30013"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:61977"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="2.7.11.1"/>
</reaction>
</comment>
<comment type="subunit">
<text evidence="16 21 22 23 24 31 32 36 38 39 40 41 44 49 50 55 57 58 62 65 66 68 69 70">Homodimer (PubMed:21145761). Interacts with DDX3X, TIRAP and TRAF2 (PubMed:10581243, PubMed:14530355). Part of a ternary complex consisting of TANK, TRAF2 and TBK1 (PubMed:10581243). Interacts with AZI2, TANK and TBKBP1; these interactions are mutually exclusive and mediate TBK1 activation (PubMed:14560022, PubMed:21931631, PubMed:23453972, PubMed:10581243, PubMed:29251827). Interacts with GSK3B; this interaction promotes TBK1 self-association and autophosphorylation (PubMed:21145761). Interacts with SIKE1; SIKE1 is associated with TBK1 under physiological condition and dissociated from TBK1 upon viral infection or TLR3 stimulation (PubMed:16281057). Interacts with IRF3, leading to IRF3 phosphorylation (PubMed:14703513, PubMed:25636800). Interacts with DDX58/RIG-I (PubMed:16281057). Interacts with CYLD (PubMed:18636086). Interacts with OPTN and TRAF3 (PubMed:20174559). Interacts with SRC (PubMed:19419966). Interacts with the exocyst complex subunit SEC5/EXOC2; this interaction is sufficient to trigger TBK1 activity (PubMed:17018283). Interacts with STING1, leading to STING1 phosphorylation (PubMed:19416887, PubMed:25636800, PubMed:30842653). Interacts with IFIT3 (via N-terminus) (PubMed:21813773). Interacts with MAVS; interaction only takes place in the presence of IFIT3 and leads to MAVS phosphorylation (PubMed:21813773, PubMed:25636800, PubMed:28011935). Interacts (via protein kinase domain) with TTLL12 (via TTL domain); the interaction prevents MAVS binding to TBK1 (PubMed:28011935). Interacts with TICAM1; this interaction is enhanced in the presence of WDFY1 and leads to TICAM1 phosphorylation (PubMed:14530355, PubMed:14739303, PubMed:25736436, PubMed:25636800). Interacts with TRIM26 (PubMed:26611359). Interacts with TRIM23 (PubMed:28871090). Interacts with TTC4 and IKBKE (PubMed:29251827). Interacts with HNRNPA2B1 (PubMed:31320558). Interacts with DDX3X (PubMed:20375222).</text>
</comment>
<comment type="subunit">
<text evidence="30">(Microbial infection) Interacts with Borna disease virus (BDV) P protein leading to its phosphorylation.</text>
</comment>
<comment type="subunit">
<text evidence="37">(Microbial infection) Interacts with Ebola virus protein VP35.</text>
</comment>
<comment type="subunit">
<text evidence="29">(Microbial infection) Interacts with HCV NS3; this interaction leads to inhibition of cellular antiviral response by blocking necessary interactions between the TBK1 and its substrates IRF3 and IRF7.</text>
</comment>
<comment type="subunit">
<text evidence="67">(Microbial infection) Interacts with herpes simplex virus 1 protein ICP34.5.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-9543922">
<id>I0DF37</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-9518472">
<id>I6W9F2</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-8788634">
<id>K7Y1A2</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-6919131">
<id>PRO_0000037572</id>
<dbReference type="UniProtKB" id="P27958"/>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-3649474">
<id>PRO_0000037573</id>
<dbReference type="UniProtKB" id="P27958"/>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-528269">
<id>Q9UKV8</id>
<label>AGO2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-727146">
<id>Q7Z3C6</id>
<label>ATG9A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-359973">
<id>Q9H6S1</id>
<label>AZI2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-739580">
<id>Q13137</id>
<label>CALCOCO2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-689124">
<id>Q6DT37</id>
<label>CDC42BPG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-773173">
<id>Q62167</id>
<label>Ddx3x</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-9544132">
<id>O41932</id>
<label>GAMMAHV.ORF11</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-3922712">
<id>Q9Y6W8</id>
<label>ICOS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-307369">
<id>Q14164</id>
<label>IKBKE</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
<label>IKBKG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-2650369">
<id>Q14653</id>
<label>IRF3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-968267">
<id>Q92985</id>
<label>IRF7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
<label>MAVS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-2129148">
<id>Q86YT6</id>
<label>MIB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-2130249">
<id>Q96AX9</id>
<label>MIB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-2556166">
<id>Q9NVV4</id>
<label>MTPAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
<label>OPTN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-1047061">
<id>O14730</id>
<label>RIOK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-1186478">
<id>P42226</id>
<label>STAT6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-356349">
<id>Q92844</id>
<label>TANK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-359969">
<id>A7MCY6</id>
<label>TBKBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-525995">
<id>Q8IUC6</id>
<label>TICAM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-2800345">
<id>Q86WV6</id>
<label>TMEM173</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-355744">
<id>Q12933</id>
<label>TRAF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-1050890">
<id>O95801</id>
<label>TTC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-359793">
<id>P40222</id>
<label>TXLNA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-6116854">
<id>Q8BHN1</id>
<label>Txlng</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
</interactant>
<interactant intactId="EBI-6148294">
<id>Q05127</id>
<label>VP35</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="26 49 68">Cytoplasm</location>
</subcellularLocation>
<text evidence="32">Upon mitogen stimulation or triggering of the immune system, TBK1 is recruited to the exocyst by EXOC2.</text>
</comment>
<comment type="tissue specificity">
<text evidence="17 46">Ubiquitous with higher expression in testis. Expressed in the ganglion cells, nerve fiber layer and microvasculature of the retina.</text>
</comment>
<comment type="domain">
<text evidence="34 42">Comprises A N-terminal kinase domain, a ubiquitin-like domain and a C-terminal coiled-coil region mediating homodimerization.</text>
</comment>
<comment type="PTM">
<text evidence="18 43 54 56">Autophosphorylation at Ser-172 activates the kinase, and is an essential step for virus-triggered signaling. Phosphorylated by IKBKB/IKKB at Ser-172. Phosphorylation requires homodimerization and ubiquitination at Lys-30 and Lys-401. Dephosphorylated at Ser-172 by PPM1B and this negatively regulates its role in mediating antiviral response.</text>
</comment>
<comment type="PTM">
<text evidence="52 54 64">'Lys-63'-linked polyubiquitination by MIB1 after RNA virus infection, or by NRDP1 after LPS stimulation at Lys-30 and Lys-401, participates in kinase activation. 'Lys-48'-linked polyubiquitination at Lys-670 by DTX4 leads to proteasomal degradation. 'Lys-48'-linked polyubiquitination by TRAIP also leads to proteasomal degradation. 'Lys-63'-linked polyubiquitination by RNF128 at Lys-30 and Lys-401 leads to the activation of antiviral responses.</text>
</comment>
<comment type="disease" evidence="46 51">
<disease id="DI-03709">
<name>Glaucoma 1, open angle, P</name>
<acronym>GLC1P</acronym>
<description>A form of primary open angle glaucoma (POAG). POAG is characterized by a specific pattern of optic nerve and visual field defects. The angle of the anterior chamber of the eye is open, and usually the intraocular pressure is increased. However, glaucoma can occur at any intraocular pressure. The disease is generally asymptomatic until the late stages, by which time significant and irreversible optic nerve damage has already taken place. GLC1P is characterized by early onset, thin central corneas and low intraocular pressure.</description>
<dbReference type="MIM" id="177700"/>
</disease>
<text evidence="46">The disease may be caused by mutations affecting the gene represented in this entry. A copy number variation on chromosome 12q14 consisting of a 300 kb duplication that includes TBK1, XPOT, RASSF3 and GNS has been found in individuals affected by glaucoma. TBK1 is the most likely candidate for the disorder (PubMed:21447600).</text>
</comment>
<comment type="disease" evidence="59 60">
<disease id="DI-04472">
<name>Frontotemporal dementia and/or amyotrophic lateral sclerosis 4</name>
<acronym>FTDALS4</acronym>
<description>A neurodegenerative disorder characterized by frontotemporal dementia and/or amyotrophic lateral sclerosis in affected individuals. There is high intrafamilial variation. Frontotemporal dementia is characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Amyotrophic lateral sclerosis is characterized by the death of motor neurons in the brain, brainstem, and spinal cord, resulting in fatal paralysis.</description>
<dbReference type="MIM" id="616439"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="53 61">
<disease id="DI-05212">
<name>Encephalopathy, acute, infection-induced, herpes-specific, 8</name>
<acronym>IIAE8</acronym>
<description>A rare, often fatal complication of herpes simplex infection, caused by virus spreading in the central nervous system. Disease manifestations include low-grade fever, severe headache, nausea, vomiting, and lethargy. Neurological features include confusion, acute memory disturbances, disorientation, behavioral changes, hemiparesis and seizures.</description>
<dbReference type="MIM" id="617900"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text evidence="74">In cancer cells, pathological TBK1 activation promotes oncogenic transformation by suppressing programmed cell death. Mechanistically, the RALB-SEC5/EXOC2-TBK1 signaling cascade seems to participate in both innate immune signaling and cell transformation. Additionally, TBK1 supports oncogenesis by directly phosphorylating and activating AKT1 at the exocyst (PubMed:21042276).</text>
</comment>
<comment type="similarity">
<text evidence="15">Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. I-kappa-B kinase subfamily.</text>
</comment>
<comment type="sequence caution" evidence="73">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA92129" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<dbReference type="EC" id="2.7.11.1" evidence="25 35 43 45 47 48 57"/>
<dbReference type="EMBL" id="AF191838">
<property type="protein sequence ID" value="AAF05989.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF174536">
<property type="protein sequence ID" value="AAF69106.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK002192">
<property type="protein sequence ID" value="BAA92129.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291039">
<property type="protein sequence ID" value="BAF83728.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471054">
<property type="protein sequence ID" value="EAW97133.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC034950">
<property type="protein sequence ID" value="AAH34950.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8968.1"/>
<dbReference type="RefSeq" id="NP_037386.1">
<property type="nucleotide sequence ID" value="NM_013254.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005268866.1">
<property type="nucleotide sequence ID" value="XM_005268809.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005268867.1">
<property type="nucleotide sequence ID" value="XM_005268810.1"/>
</dbReference>
<dbReference type="PDB" id="4EFO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.77"/>
<property type="chains" value="A/B=302-383"/>
</dbReference>
<dbReference type="PDB" id="4EUT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=2-385"/>
</dbReference>
<dbReference type="PDB" id="4EUU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=2-308"/>
</dbReference>
<dbReference type="PDB" id="4IM0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=1-657"/>
</dbReference>
<dbReference type="PDB" id="4IM2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1-657"/>
</dbReference>
<dbReference type="PDB" id="4IM3">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.34"/>
<property type="chains" value="A=1-657"/>
</dbReference>
<dbReference type="PDB" id="4IW0">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.00"/>
<property type="chains" value="A=2-657"/>
</dbReference>
<dbReference type="PDB" id="4IWO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.61"/>
<property type="chains" value="A=2-657"/>
</dbReference>
<dbReference type="PDB" id="4IWP">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.06"/>
<property type="chains" value="A=2-657"/>
</dbReference>
<dbReference type="PDB" id="4IWQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=2-657"/>
</dbReference>
<dbReference type="PDB" id="5EOA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="C/D=677-729"/>
</dbReference>
<dbReference type="PDB" id="5EOF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="C/D=677-729"/>
</dbReference>
<dbReference type="PDB" id="5EP6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="B/D=677-729"/>
</dbReference>
<dbReference type="PDB" id="5W5V">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.65"/>
<property type="chains" value="A=1-657"/>
</dbReference>
<dbReference type="PDB" id="6BNY">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.34"/>
<property type="chains" value="A=1-657"/>
</dbReference>
<dbReference type="PDB" id="6BOD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=1-657"/>
</dbReference>
<dbReference type="PDB" id="6BOE">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="A=1-657"/>
</dbReference>
<dbReference type="PDB" id="6CQ0">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.19"/>
<property type="chains" value="A=1-657"/>
</dbReference>
<dbReference type="PDB" id="6CQ4">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=1-657"/>
</dbReference>
<dbReference type="PDB" id="6CQ5">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.35"/>
<property type="chains" value="A=1-657"/>
</dbReference>
<dbReference type="PDB" id="6NT9">
<property type="method" value="EM"/>
<property type="resolution" value="3.3"/>
<property type="chains" value="A/B=1-729"/>
</dbReference>
<dbReference type="PDB" id="6O8B">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A/B=2-657"/>
</dbReference>
<dbReference type="PDB" id="6RSR">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.15"/>
<property type="chains" value="A=2-657"/>
</dbReference>
<dbReference type="PDB" id="6RST">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.29"/>
<property type="chains" value="A=2-657"/>
</dbReference>
<dbReference type="PDBsum" id="4EFO"/>
<dbReference type="PDBsum" id="4EUT"/>
<dbReference type="PDBsum" id="4EUU"/>
<dbReference type="PDBsum" id="4IM0"/>
<dbReference type="PDBsum" id="4IM2"/>
<dbReference type="PDBsum" id="4IM3"/>
<dbReference type="PDBsum" id="4IW0"/>
<dbReference type="PDBsum" id="4IWO"/>
<dbReference type="PDBsum" id="4IWP"/>
<dbReference type="PDBsum" id="4IWQ"/>
<dbReference type="PDBsum" id="5EOA"/>
<dbReference type="PDBsum" id="5EOF"/>
<dbReference type="PDBsum" id="5EP6"/>
<dbReference type="PDBsum" id="5W5V"/>
<dbReference type="PDBsum" id="6BNY"/>
<dbReference type="PDBsum" id="6BOD"/>
<dbReference type="PDBsum" id="6BOE"/>
<dbReference type="PDBsum" id="6CQ0"/>
<dbReference type="PDBsum" id="6CQ4"/>
<dbReference type="PDBsum" id="6CQ5"/>
<dbReference type="PDBsum" id="6NT9"/>
<dbReference type="PDBsum" id="6O8B"/>
<dbReference type="PDBsum" id="6RSR"/>
<dbReference type="PDBsum" id="6RST"/>
<dbReference type="SMR" id="Q9UHD2"/>
<dbReference type="BioGrid" id="118878">
<property type="interactions" value="154"/>
</dbReference>
<dbReference type="CORUM" id="Q9UHD2"/>
<dbReference type="DIP" id="DIP-27529N"/>
<dbReference type="IntAct" id="Q9UHD2">
<property type="interactions" value="106"/>
</dbReference>
<dbReference type="MINT" id="Q9UHD2"/>
<dbReference type="STRING" id="9606.ENSP00000329967"/>
<dbReference type="BindingDB" id="Q9UHD2"/>
<dbReference type="ChEMBL" id="CHEMBL5408"/>
<dbReference type="DrugBank" id="DB12010">
<property type="generic name" value="Fostamatinib"/>
</dbReference>
<dbReference type="DrugCentral" id="Q9UHD2"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2237"/>
<dbReference type="iPTMnet" id="Q9UHD2"/>
<dbReference type="MetOSite" id="Q9UHD2"/>
<dbReference type="PhosphoSitePlus" id="Q9UHD2"/>
<dbReference type="BioMuta" id="TBK1"/>
<dbReference type="DMDM" id="74761953"/>
<dbReference type="CPTAC" id="CPTAC-910"/>
<dbReference type="CPTAC" id="CPTAC-911"/>
<dbReference type="EPD" id="Q9UHD2"/>
<dbReference type="jPOST" id="Q9UHD2"/>
<dbReference type="MassIVE" id="Q9UHD2"/>
<dbReference type="MaxQB" id="Q9UHD2"/>
<dbReference type="PaxDb" id="Q9UHD2"/>
<dbReference type="PeptideAtlas" id="Q9UHD2"/>
<dbReference type="PRIDE" id="Q9UHD2"/>
<dbReference type="ProteomicsDB" id="84323"/>
<dbReference type="Antibodypedia" id="16584">
<property type="antibodies" value="581 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="29110"/>
<dbReference type="Ensembl" id="ENST00000331710">
<property type="protein sequence ID" value="ENSP00000329967"/>
<property type="gene ID" value="ENSG00000183735"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000650790">
<property type="protein sequence ID" value="ENSP00000498995"/>
<property type="gene ID" value="ENSG00000183735"/>
</dbReference>
<dbReference type="GeneID" id="29110"/>
<dbReference type="KEGG" id="hsa:29110"/>
<dbReference type="UCSC" id="uc001ssc.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="29110"/>
<dbReference type="DisGeNET" id="29110"/>
<dbReference type="GeneCards" id="TBK1"/>
<dbReference type="HGNC" id="HGNC:11584">
<property type="gene designation" value="TBK1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000183735">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="TBK1"/>
<dbReference type="MIM" id="177700">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="604834">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="616439">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="617900">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9UHD2"/>
<dbReference type="OpenTargets" id="ENSG00000183735"/>
<dbReference type="Orphanet" id="803">
<property type="disease" value="Amyotrophic lateral sclerosis"/>
</dbReference>
<dbReference type="Orphanet" id="275872">
<property type="disease" value="Frontotemporal dementia with motor neuron disease"/>
</dbReference>
<dbReference type="Orphanet" id="1930">
<property type="disease" value="Herpes simplex virus encephalitis"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36348"/>
<dbReference type="eggNOG" id="KOG4250">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XRMU">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00950000182937"/>
<dbReference type="HOGENOM" id="CLU_000288_101_1_1"/>
<dbReference type="InParanoid" id="Q9UHD2"/>
<dbReference type="KO" id="K05410"/>
<dbReference type="OMA" id="RWLIEII"/>
<dbReference type="OrthoDB" id="563981at2759"/>
<dbReference type="PhylomeDB" id="Q9UHD2"/>
<dbReference type="TreeFam" id="TF324269"/>
<dbReference type="Reactome" id="R-HSA-1606341">
<property type="pathway name" value="IRF3 mediated activation of type 1 IFN"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3134975">
<property type="pathway name" value="Regulation of innate immune responses to cytosolic DNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3249367">
<property type="pathway name" value="STAT6-mediated induction of chemokines"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3270619">
<property type="pathway name" value="IRF3-mediated induction of type I IFN"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9008059">
<property type="pathway name" value="Interleukin-37 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9013973">
<property type="pathway name" value="TICAM1-dependent activation of IRF3/IRF7"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-918233">
<property type="pathway name" value="TRAF3-dependent IRF activation pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933541">
<property type="pathway name" value="TRAF6 mediated IRF7 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-936440">
<property type="pathway name" value="Negative regulators of DDX58/IFIH1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-936964">
<property type="pathway name" value="Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q9UHD2"/>
<dbReference type="SignaLink" id="Q9UHD2"/>
<dbReference type="SIGNOR" id="Q9UHD2"/>
<dbReference type="ChiTaRS" id="TBK1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="TANK-binding_kinase_1"/>
<dbReference type="GenomeRNAi" id="29110"/>
<dbReference type="Pharos" id="Q9UHD2">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9UHD2"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="RNAct" id="Q9UHD2">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000183735">
<property type="expression patterns" value="Expressed in lateral nuclear group of thalamus and 232 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9UHD2">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9UHD2">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003676">
<property type="term" value="F:nucleic acid binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051219">
<property type="term" value="F:phosphoprotein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071345">
<property type="term" value="P:cellular response to cytokine stimulus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050830">
<property type="term" value="P:defense response to Gram-positive bacterium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0044565">
<property type="term" value="P:dendritic cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007249">
<property type="term" value="P:I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032480">
<property type="term" value="P:negative regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018107">
<property type="term" value="P:peptidyl-threonine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032727">
<property type="term" value="P:positive regulation of interferon-alpha production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045359">
<property type="term" value="P:positive regulation of interferon-beta biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032728">
<property type="term" value="P:positive regulation of interferon-beta production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016239">
<property type="term" value="P:positive regulation of macroautophagy"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0033138">
<property type="term" value="P:positive regulation of peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032481">
<property type="term" value="P:positive regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0060340">
<property type="term" value="P:positive regulation of type I interferon-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904417">
<property type="term" value="P:positive regulation of xenophagy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901214">
<property type="term" value="P:regulation of neuron death"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032479">
<property type="term" value="P:regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035666">
<property type="term" value="P:TRIF-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032606">
<property type="term" value="P:type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR041309">
<property type="entry name" value="TBK1_CCD1"/>
</dbReference>
<dbReference type="InterPro" id="IPR041087">
<property type="entry name" value="TBK1_ULD"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18394">
<property type="entry name" value="TBK1_CCD1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18396">
<property type="entry name" value="TBK1_ULD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0036">Amyotrophic lateral sclerosis</keyword>
<keyword id="KW-0051">Antiviral defense</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0955">Glaucoma</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Serine/threonine-protein kinase TBK1" id="PRO_0000086743">
<location>
<begin position="1"/>
<end position="729"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="15">
<location>
<begin position="9"/>
<end position="310"/>
</location>
</feature>
<feature type="domain" description="Ubiquitin-like">
<location>
<begin position="309"/>
<end position="385"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="15">
<location>
<begin position="15"/>
<end position="23"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with AZI2, TANK and TBKBP1" evidence="50">
<location>
<begin position="621"/>
<end position="629"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="13">
<location>
<begin position="407"/>
<end position="657"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="14">
<location>
<begin position="658"/>
<end position="713"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="75 76 77">
<location>
<position position="135"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="73">
<location>
<position position="38"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis and IKKB" evidence="18 53 56">
<location>
<position position="172"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="716"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="54">
<location>
<position position="30"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="54">
<location>
<position position="401"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="52">
<location>
<position position="670"/>
</location>
</feature>
<feature type="sequence variant" description="In FTDALS4; loss of kinase activity." id="VAR_073938" evidence="59">
<original>R</original>
<variation>H</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence variant" description="In IIAE8; decreased expression levels; dbSNP:rs1010930015." id="VAR_080517" evidence="53">
<original>D</original>
<variation>A</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="sequence variant" description="In FTDALS4; dbSNP:rs1366668789." id="VAR_073939" evidence="59">
<original>Y</original>
<variation>C</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55824172." id="VAR_069754" evidence="46">
<original>S</original>
<variation>F</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="sequence variant" description="In IIAE8; loss of kinase activity; loss of autophosphorylation at S-172; dbSNP:rs1555202947." id="VAR_080518" evidence="53">
<original>G</original>
<variation>A</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In IIAE8; unknown pathological significance; dbSNP:rs1555203557." id="VAR_080519" evidence="61">
<original>I</original>
<variation>V</variation>
<location>
<position position="207"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56196591." id="VAR_041208" evidence="33">
<original>R</original>
<variation>Q</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34774243." id="VAR_041209" evidence="33">
<original>K</original>
<variation>E</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast pleomorphic lobular carcinoma sample; somatic mutation." id="VAR_041210" evidence="33">
<original>D</original>
<variation>H</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence variant" description="In FTDALS4; dbSNP:rs770942184." id="VAR_073940" evidence="59">
<original>I</original>
<variation>T</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="sequence variant" description="In FTDALS4; unknown pathological significance; dbSNP:rs201970436." id="VAR_069755" evidence="46 60">
<original>L</original>
<variation>I</variation>
<location>
<position position="306"/>
</location>
</feature>
<feature type="sequence variant" description="In FTDALS4; reduced kinase activity." id="VAR_073941" evidence="59">
<original>R</original>
<variation>Q</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="sequence variant" description="In FTDALS4; reduced kinase activity; dbSNP:rs758357594." id="VAR_073942" evidence="59">
<original>R</original>
<variation>Q</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17857028." id="VAR_024746" evidence="28">
<original>N</original>
<variation>D</variation>
<location>
<position position="388"/>
</location>
</feature>
<feature type="sequence variant" description="In FTDALS4; dbSNP:rs756751089." id="VAR_073943" evidence="60">
<original>K</original>
<variation>E</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs1262765773." id="VAR_041211" evidence="33">
<original>G</original>
<variation>R</variation>
<location>
<position position="410"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35635889." id="VAR_041212" evidence="33 46">
<original>V</original>
<variation>A</variation>
<location>
<position position="464"/>
</location>
</feature>
<feature type="sequence variant" description="In FTDALS4; loss of kinase activity." id="VAR_073944" evidence="59">
<original>M</original>
<variation>R</variation>
<location>
<position position="559"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17853341." id="VAR_024747" evidence="28">
<original>K</original>
<variation>Q</variation>
<location>
<position position="570"/>
</location>
</feature>
<feature type="sequence variant" description="In FTDALS4; dbSNP:rs765035140." id="VAR_073945" evidence="59">
<original>A</original>
<variation>V</variation>
<location>
<position position="571"/>
</location>
</feature>
<feature type="sequence variant" description="In FTDALS4; dbSNP:rs899858451." id="VAR_073946" evidence="59">
<original>M</original>
<variation>V</variation>
<location>
<position position="598"/>
</location>
</feature>
<feature type="sequence variant" description="In FTDALS4." id="VAR_073947" evidence="59">
<location>
<position position="643"/>
</location>
</feature>
<feature type="sequence variant" description="In FTDALS4; loss of kinase activity; impairs binding to OPTN; dbSNP:rs748112833." id="VAR_073948" evidence="59 60">
<original>E</original>
<variation>K</variation>
<location>
<position position="696"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases ubiquitination. Abolishes ubiquitination, phosphorylation and kinase activity; when associated with R-401." evidence="54">
<original>K</original>
<variation>R</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases phosphorylation and kinase activity." evidence="54">
<original>D</original>
<variation>A</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="16 53 54 55">
<original>K</original>
<variation>A</variation>
<location>
<position position="38"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="50 54 55 69">
<original>D</original>
<variation>N</variation>
<location>
<position position="135"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity. No effect on dimerization." evidence="18 55">
<original>S</original>
<variation>A</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased kinase activity." evidence="18 55">
<original>S</original>
<variation>E</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases kinase activity. No effect on phosphorylation." evidence="55">
<original>L</original>
<variation>E</variation>
<location>
<position position="316"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation and kinase activity." evidence="55">
<original>Y</original>
<variation>E</variation>
<location>
<position position="325"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases phosphorylation and kinase activity. Abolishes dimerization; when associated with A-357 or R-448." evidence="54 55">
<original>E</original>
<variation>R</variation>
<location>
<position position="355"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases phosphorylation and kinase activity. Abolishes dimerization; when associated with R-355." evidence="54">
<original>R</original>
<variation>A</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases ubiquitination. Abolishes ubiquitination, phosphorylation and kinase activity; when associated with R-30." evidence="54">
<original>K</original>
<variation>R</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases phosphorylation and kinase activity. Abolishes dimerization; when associated with R-355." evidence="55">
<original>E</original>
<variation>R</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes dimerization and decreases kinase activity but no effect on phosphorylation; when associated with E-466 and E-470." evidence="55">
<original>H</original>
<variation>E</variation>
<location>
<position position="459"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes dimerization and decreases kinase activity but no effect on phosphorylation; when associated with E-459 and E-470." evidence="55">
<original>I</original>
<variation>E</variation>
<location>
<position position="466"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes dimerization and decreases kinase activity but no effect on phosphorylation; when associated with E-459 and E-466." evidence="55">
<original>F</original>
<variation>E</variation>
<location>
<position position="470"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases phosphorylation and kinase activity. Abolishes dimerization." evidence="54">
<original>R</original>
<variation>D</variation>
<location>
<position position="547"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases kinase activity. Reduced phosphorylation of STING1." evidence="54 69">
<original>Y</original>
<variation>A</variation>
<location>
<position position="577"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced phosphorylation of STING1." evidence="69">
<original>N</original>
<variation>A</variation>
<location>
<position position="578"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases kinase activity." evidence="54">
<original>E</original>
<variation>A</variation>
<location>
<position position="580"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced phosphorylation of STING1." evidence="69">
<original>Q</original>
<variation>A</variation>
<location>
<position position="581"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases kinase activity." evidence="54">
<original>I</original>
<variation>A</variation>
<location>
<position position="582"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases phosphorylation and kinase activity." evidence="54">
<original>K</original>
<variation>D</variation>
<location>
<position position="589"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases interaction with TANK." evidence="50">
<original>M</original>
<variation>A</variation>
<location>
<position position="690"/>
</location>
</feature>
<feature type="mutagenesis site" description="Almost abolishes interaction with TANK." evidence="50">
<original>L</original>
<variation>A</variation>
<location>
<position position="693"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreases interaction with TANK and TBKBP1. No effect on phosphorylation." evidence="50">
<original>K</original>
<variation>E</variation>
<location>
<position position="694"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreases interaction with AZI2, TANK and TBKBP1. No effect on phosphorylation." evidence="50">
<original>L</original>
<variation>A</variation>
<location>
<position position="704"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases interaction with TANK." evidence="50">
<original>N</original>
<variation>A</variation>
<location>
<position position="708"/>
</location>
</feature>
<feature type="mutagenesis site" description="Almost abolishes interaction with TANK." evidence="50">
<original>L</original>
<variation>A</variation>
<location>
<position position="711"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="1"/>
<end position="3"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="5"/>
<end position="17"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="19"/>
<end position="28"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="29"/>
<end position="31"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="34"/>
<end position="40"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="42"/>
<end position="46"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="49"/>
<end position="61"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="65"/>
<end position="67"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="70"/>
<end position="75"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="77"/>
<end position="79"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="82"/>
<end position="87"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="94"/>
<end position="99"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="101"/>
<end position="103"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="109"/>
<end position="128"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="138"/>
<end position="140"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="141"/>
<end position="145"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="151"/>
<end position="155"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="161"/>
<end position="163"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="167"/>
<end position="169"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="173"/>
<end position="175"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="177"/>
<end position="179"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="182"/>
<end position="188"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="202"/>
<end position="216"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="220"/>
<end position="222"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="227"/>
<end position="229"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="231"/>
<end position="240"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="247"/>
<end position="250"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="252"/>
<end position="254"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="257"/>
<end position="262"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="271"/>
<end position="284"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="285"/>
<end position="287"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="289"/>
<end position="291"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="305"/>
<end position="307"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="308"/>
<end position="315"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="316"/>
<end position="319"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="320"/>
<end position="327"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="332"/>
<end position="343"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="347"/>
<end position="349"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="350"/>
<end position="354"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="357"/>
<end position="359"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="367"/>
<end position="369"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="375"/>
<end position="377"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="379"/>
<end position="383"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="408"/>
<end position="480"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="498"/>
<end position="526"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="530"/>
<end position="532"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="535"/>
<end position="539"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="544"/>
<end position="546"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="548"/>
<end position="571"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="572"/>
<end position="574"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="577"/>
<end position="603"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="605"/>
<end position="647"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="648"/>
<end position="651"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="680"/>
<end position="714"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="715"/>
<end position="717"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4EFO"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4EUT"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4EUU"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4IM0"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4IWO"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4IWP"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4IWQ"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5EP6"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6CQ0"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6NT9"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6O8B"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9WUN2"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255"/>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10581243"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10783893"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11839743"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12692549"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12702806"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14530355"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14560022"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14703513"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14739303"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15367631"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15485837"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489227"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15841462"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16155125"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16281057"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17018283"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17599067"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18583960"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18636086"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19153231"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19416887"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19419966"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20174559"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20375222"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21042276"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21138416"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21145761"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21270402"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21447600"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21464307"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21617041"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21813773"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21931631"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22306015"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22388039"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22851595"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23453971"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23453972"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23746807"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25636800"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25736436"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25803835"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25943890"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26513235"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26611359"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27103069"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27776110"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28011935"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28871090"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28904192"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29251827"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30842653"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31320558"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10581243"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10783893"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000305"/>
<evidence key="74" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21042276"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="23453971"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="23453972"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="30842653"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:11584"/>
</source>
</evidence>
<sequence length="729" mass="83642" checksum="B58E4FE1B502276D" modified="2000-05-01" version="1">MQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQETLPQKMFTASSGIKHTMTPIYPSSNTLVEMTLGMKKLKEEMEGVVKELAENNHILERFGSLTMDGGLRNVDCL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>